BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22966065)

  • 1. The p35 human invariant chain in transgenic mice restores mature B cells in the absence of endogenous CD74.
    Genève L; Ménard C; Labrecque N; Thibodeau J
    Int Immunol; 2012 Oct; 24(10):645-60. PubMed ID: 22966065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
    Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
    Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
    Khalil H; Brunet A; Thibodeau J
    J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
    J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice deficient in invariant-chain and MHC class II exhibit a normal mature B2 cell compartment.
    Maehr R; Kraus M; Ploegh HL
    Eur J Immunol; 2004 Aug; 34(8):2230-6. PubMed ID: 15259020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
    Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
    Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity.
    Matza D; Lantner F; Bogoch Y; Flaishon L; Hershkoviz R; Shachar I
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3018-23. PubMed ID: 11867743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.
    Sevilla LM; Richter SS; Miller J
    Cell Immunol; 2001 Jun; 210(2):143-53. PubMed ID: 11520080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal.
    Khalil H; Brunet A; Saba I; Terra R; Sékaly RP; Thibodeau J
    Int Immunol; 2003 Oct; 15(10):1249-63. PubMed ID: 13679394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The invariant chain transports TNF family member CD70 to MHC class II compartments in dendritic cells.
    Zwart W; Peperzak V; de Vries E; Keller AM; van der Horst G; Veraar EA; Geumann U; Janssen H; Janssen L; Naik SH; Neefjes J; Borst J
    J Cell Sci; 2010 Nov; 123(Pt 21):3817-27. PubMed ID: 20971706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
    Thayer WP; Ignatowicz L; Weber DA; Jensen PE
    J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BALB/c invariant chain mutant mice display relatively efficient maturation of CD4+ T cells in the periphery and secondary proliferative responses elicited upon peptide challenge.
    Kenty G; Bikoff EK
    J Immunol; 1999 Jul; 163(1):232-41. PubMed ID: 10384121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human-specific invariant chain isoform Iip35 modulates Iip33 trafficking and function.
    Sand KM; Landsverk OJ; Berg-Larsen A; Bakke O; Gregers TF
    Immunol Cell Biol; 2014 Oct; 92(9):791-8. PubMed ID: 24983457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
    Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
    Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.
    Kuwana T; Peterson PA; Karlsson L
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1056-61. PubMed ID: 9448284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
    Honey K; Forbush K; Jensen PE; Rudensky AY
    J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
    Gautam AM; Yang M; Milburn PJ; Baker R; Bhatnagar A; McCluskey J; Boston T
    J Immunol; 1997 Sep; 159(6):2782-8. PubMed ID: 9300699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of MHC Class II on B Cell Defects Induced by Invariant Chain/CD74 N-Terminal Fragments.
    Schneppenheim J; Loock AC; Hüttl S; Schweizer M; Lüllmann-Rauch R; Oberg HH; Arnold P; Lehmann CHK; Dudziak D; Kabelitz D; Lucius R; Lennon-Duménil AM; Saftig P; Schröder B
    J Immunol; 2017 Jul; 199(1):172-185. PubMed ID: 28550201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.